Recently added articles from Proteomics Weekly:
Investigators at Hubei University have published new data on enzyme research.
Dec 21, 2009 ... "A novel surface-display system was constructed using the cell-wall anchor protein Flolp from Saccharomyces cerevisiae, the mannanase (man I) from Bacillus subtilis fused with the C-terminus of Flolp and the 6 x His tag was inserted between Flolp and manl. The fusion protein was displayed ...
New findings from C.L. Martynsimmons and co-authors in the area of monoclonal antibodies published.
Dec 21, 2009 ... "Targeted biologic therapies have made a significant impact on the treatment for moderate to severe psoriasis. In the United Kingdom, the National Institute for Health and Clinical Excellence recommends etanercept, a human recombinant tumour necrosis factor (TNF) receptor fusion protein, ...
New hepatitis B virus study findings reported from Third Military Medical University.
Dec 21, 2009 ... "The HBx (hepatitis B virus X protein) is a multifunctional regulator of cellular signal transduction and transcription pathways in host-infected cells. Evidence suggests that HBx has a critical role in the pathogenesis of hepatocellular carcinoma," scientists writing in the journal ...
Scientists at University of Kent target life sciences.
Dec 21, 2009 ... According to recent research from Canterbury, the United Kingdom, "Biopharmaceutical proteins are often formulated and freeze dried in agents that protect them from deleterious reactions that can compromise activity and authenticity. Although such approaches are widely used, a detailed ...
Scientists at University of Minnesota publish research in glioblastoma.
Dec 21, 2009 ... "A bispecific ligand-directed toxin (BLT) consisting of human interleukin-13, epithelial growth factor, and the first 389 amino acids of diphtheria toxin was assembled in order to target human glioblastoma. In vitro, DTEGF13 selectively killed the human glioblastoma cell line U87-luc as ...